Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

K Weisel; M Dimopoulos; KW Song; P Moreau; A Palumbo; A Belch; S Schey; Pieter Sonneveld; L Sternas; X Yu; R Amatya; C J Gibson; M Zaki; C Jacques; J San Miguel

doi:10.1016/j.clml.2015.05.007

Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

K Weisel, M Dimopoulos, KW Song, P Moreau, A Palumbo, A Belch, S Schey, Pieter Sonneveld, L Sternas, X Yu, R Amatya, C J Gibson, M Zaki, C Jacques, J San Miguel

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

39 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	519-530
Number of pages	12
Journal	Clinical Lymphoma Myeloma & Leukemia
Volume	15
Issue number	9
DOIs	https://doi.org/10.1016/j.clml.2015.05.007
Publication status	Published - 2015

Access to Document

10.1016/j.clml.2015.05.007

http://hdl.handle.net/1765/83744

Cite this

Weisel, K., Dimopoulos, M., Song, KW., Moreau, P., Palumbo, A., Belch, A., Schey, S., Sonneveld, P., Sternas, L., Yu, X., Amatya, R., Gibson, C. J., Zaki, M., Jacques, C., & San Miguel, J. (2015). Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial. Clinical Lymphoma Myeloma & Leukemia, 15(9), 519-530. https://doi.org/10.1016/j.clml.2015.05.007

@article{ca258a7c36c64041b28ef8c1417bafac,

title = "Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial",

author = "K Weisel and M Dimopoulos and KW Song and P Moreau and A Palumbo and A Belch and S Schey and Pieter Sonneveld and L Sternas and X Yu and R Amatya and Gibson, {C J} and M Zaki and C Jacques and {San Miguel}, J",

year = "2015",

doi = "10.1016/j.clml.2015.05.007",

language = "Undefined/Unknown",

volume = "15",

pages = "519--530",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

number = "9",

}

Weisel, K, Dimopoulos, M, Song, KW, Moreau, P, Palumbo, A, Belch, A, Schey, S, Sonneveld, P, Sternas, L, Yu, X, Amatya, R, Gibson, CJ, Zaki, M, Jacques, C & San Miguel, J 2015, 'Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial', Clinical Lymphoma Myeloma & Leukemia, vol. 15, no. 9, pp. 519-530. https://doi.org/10.1016/j.clml.2015.05.007

Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial. / Weisel, K; Dimopoulos, M; Song, KW et al.

In: Clinical Lymphoma Myeloma & Leukemia, Vol. 15, No. 9, 2015, p. 519-530.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

AU - Weisel, K

AU - Dimopoulos, M

AU - Song, KW

AU - Moreau, P

AU - Palumbo, A

AU - Belch, A

AU - Schey, S

AU - Sonneveld, Pieter

AU - Sternas, L

AU - Yu, X

AU - Amatya, R

AU - Gibson, C J

AU - Zaki, M

AU - Jacques, C

AU - San Miguel, J

PY - 2015

Y1 - 2015

U2 - 10.1016/j.clml.2015.05.007

DO - 10.1016/j.clml.2015.05.007

M3 - Article

VL - 15

SP - 519

EP - 530

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2650

IS - 9

ER -

Weisel K, Dimopoulos M, Song KW, Moreau P, Palumbo A, Belch A et al. Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial. Clinical Lymphoma Myeloma & Leukemia. 2015;15(9):519-530. doi: 10.1016/j.clml.2015.05.007